SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/09/22 Acadia Pharmaceuticals Inc. S-8 8/09/22 5:190K Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: S-8 Registration Statement - Securities for an HTML 35K Employee Benefit Plan 2: EX-5.1 Opinion of Counsel re: Legality HTML 9K 3: EX-23.1 Consent of Expert or Counsel HTML 5K 5: EX-FILING FEES Filing Fees HTML 15K 4: EX-99.1 Miscellaneous Exhibit HTML 128K
Page | (sequential) | (alphabetic) | ↑Top | ||
---|---|---|---|---|---|
1 | 1st Page – Filing Submission | ||||
" | Power of Attorney (included on the signature page) |
S-8 |
As filed with the Securities and Exchange Commission on August 8, 2022
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
ACADIA PHARMACEUTICALS INC.
(Exact Name of Registrant as Specified in Its Charter)
Delaware | 06-1376651 | |
(State or Other Jurisdiction of Incorporation or Organization) |
(I.R.S. Employer Identification No.) |
12830 El Camino Real, Suite 400
(858) 558-2871
(Address of Principal Executive Offices, Including Zip Code)
Acadia Pharmaceuticals Inc.
2010 Equity Incentive Plan
(Full Title of the Plan)
Austin D. Kim
Executive Vice President, General Counsel & Secretary
Acadia Pharmaceuticals Inc.
12830 El Camino Real, Suite 400
(Name and Address of Agent for Service)
(858) 558-2871
(Telephone Number, Including Area Code, of Agent for Service)
Copies to:
L. Kay Chandler, Esq.
Carlos Ramirez, Esq.
Cooley LLP
4401 Eastgate Mall
(858) 550-6000
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act:
Large accelerated filer | ☒ | Accelerated filer | ☐ | |||
Non-accelerated filer | ☐ | Smaller reporting company | ☐ | |||
Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
INCORPORATION BY REFERENCE OF CONTENTS OF
REGISTRATION STATEMENTS ON FORM S-8
The contents of: (i) the Registration Statement on Form S-8 (File No. 333-168667) originally filed with the Securities and Exchange Commission on August 9, 2010, as subsequently amended on August 19, 2011; (ii) the Registration Statement on Form S-8 (File No. 333-190400) filed with the Securities and Exchange Commission on August 6, 2013; (iii) the Registration Statement on Form S-8 (File No. 333-207971) filed with the Securities and Exchange Commission on November 12, 2015; (iv) the Registration Statement on Form S-8 (File No. 333-213109) filed with the Securities and Exchange Commission on August 12, 2016; (v) the Registration Statement on Form S-8 (File No. 333-219785) filed with the Securities and Exchange Commission on August 8, 2017; (vi) the Registration Statement on Form S-8 (File No. 333-226834) filed with the Securities and Exchange Commission on August 14, 2018; and (vii) the Registration Statement on Form S-8 (File No. 333-232981) filed with the Securities and Exchange Commission on August 2, 2019 are each incorporated by reference herein.
Item 8. Exhibits
* |
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Diego, State of California, on August 8, 2022.
ACADIA PHARMACEUTICALS INC. | ||
By: | /s/ Stephen R. Davis | |
Stephen R. Davis | ||
Chief Executive Officer |
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Stephen R. Davis and Austin D. Kim, and each of them, his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or either of them, or their or his substitutes or substitute, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.
Signature |
Title |
Date | ||||||
/s/ Stephen R. Davis |
Chief Executive Officer and Director (Principal Executive Officer) |
August 8, 2022 | ||||||
/s/ Mark C. Schneyer |
Executive Vice President and Chief Financial Officer (Principal Financial Officer) |
August 8, 2022 | ||||||
/s/ James K. Kihara |
Vice President, Chief Accounting Officer and Controller (Principal Accounting Officer) |
August 8, 2022 | ||||||
Chairman of the Board | August 8, 2022 | |||||||
/s/ Julian C. Baker |
Director | August 8, 2022 | ||||||
/s/ Laura A. Brege |
Director | August 8, 2022 | ||||||
/s/ James M. Daly |
Director | August 8, 2022 | ||||||
Director | August 8, 2022 | |||||||
Director | August 8, 2022 | |||||||
/s/ Daniel B. Soland |
Director | August 8, 2022 |
This ‘S-8’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed as of / Effective on: | 8/9/22 | 10-Q | ||
Filed on: | 8/8/22 | 10-Q, 8-K | ||
List all Filings |